On August 20th, 2026, Nature Aging published new research co-authored by AFAR Grantees Peter Adams, PhD, Nirmalya Dasgupta, PhD, and Karl Miller, PhD, as well as Cristofalo Award Recipient Laura J. Niedernhofer, MD, PhD. Their research explores the previously unrecognized connection between the protein cyclin D1 in “zombie” cells, or senescent cells that have stopped dividing, and chronic inflammation associated with aging and age-related diseases.
Dr. Adams is a 2018 Glenn Foundation for Medical Research Postdoctoral Fellowships in Aging Research recipient.
Dr. Dasgupta is a 2019 Glenn Foundation for Medical Research Postdoctoral Fellowships in Aging Research recipient.
Dr. Miller is a 2018 Glenn Foundation for Medical Research Postdoctoral Fellowships in Aging Research recipient.
Dr. Niedernhofer is the 2018 Vincent Cristofalo Rising Star Award in Aging Research recipient, a former AFAR Board Member, and the Co-Director of the Minnesota Nathan Shock Center of Excellence on Genome Integrity and Aging.
Read “Inhibiting cyclin D1–CDK6 suppresses senescence-associated inflammatory gene expression and age-related functional decline” here.
Read more in a related Sanford Burnham Prebys press release.
For more insights from Dr. Niedernhofer, join us for our upcoming free webinar “When Zombie Cells Attack: How Geroscience is Fighting Back to Extend Healthspan,” presented with The Nathan Shock Center Coordinating Center (NSC3), on October 8th, at 3pm ET. Register here.
